MAY 14, 2020 6:42 AM PDT

Antibody-laden Nanoparticles to Help COVID Patients Breathe Easy

WRITTEN BY: Tara Fernandez

 

Antibodies are a powerful countermeasure against COVID-19. Not only can they relieve symptoms in patients experiencing severe forms of the disease, but they can also be deployed as a “temporary vaccine”, protecting vulnerable individuals from infection.

Biopharmaceutical companies are working on an inhaled COVID-19 drug consisting of aerosolized nanoparticles containing mRNA antibodies. These nanoparticles can penetrate tissues and deliver the genetic instructions for the antibodies, in the form of mRNA, directly into cells lining the respiratory tract. In response, the cellular machinery then produces and releases high levels of the virus-binding antibody into the lungs, neutralizing SARS-CoV-2 and resisting infection.

In a pandemic situation, mRNA drugs can be swiftly deployed and accelerated through drug development pipelines. This approach was successfully demonstrated in 2019 against another viral pathogen, the Chikungunya virus. Here, mRNA antibodies administered to healthy adults protected them against severe infection from the mosquito-borne virus.

A similar approach could help ease the ongoing COVID-19 crisis. Gita Dittmar, CEO of  German RNA biotech, Ethris, said, “To cure COVID-19, the virus has to be cleared systemically. This may eventually be achieved by the patients’ natural immune response against the virus, or, once developed, by systemic treatments against the virus.”

“Our goal is to rapidly treat lung disease in patients with COVID-19 to gain time for systemic clearance of the virus and to reduce major lung complications,” Dittmar explains.

The drug development project is a collaboration between Ethris and Swiss antibody company, Neurimmune. The company has another human monoclonal antibody for the treatment of early Alzheimer’s disease currently in development.

While there are currently no clinically-approved mRNA drugs on the market, evidence from similar therapeutics in development suggest that such treatments could be safe and effective. This drug joins a long list of other pharmaceutical agents against SARS-CoV-2 that are being evaluated, from antiviral therapies to anti-inflammatory treatments.

 

 

Sources: Labiotech, Neurimmune, Ethris.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
DEC 28, 2020
Genetics & Genomics
Mapping Networks of Gene Expression in Cells
DEC 28, 2020
Mapping Networks of Gene Expression in Cells
Every cell contains our whole genome, but not all genes are turned on all the time; gene expression has to be very caref ...
JAN 14, 2021
Immunology
Sunshine Vitamin Lowers COVID Mortality
JAN 14, 2021
Sunshine Vitamin Lowers COVID Mortality
Vitamin D is sometimes referred to as the “sunshine vitamin” because it’s synthesized in the skin afte ...
MAR 31, 2021
Microbiology
Deep-Sea Microbes Are 'Invisible' to the Human Immune System
MAR 31, 2021
Deep-Sea Microbes Are 'Invisible' to the Human Immune System
Scientists took an exploratory journey to a place in the central Pacific Ocean in Kirbati called the Phoenix Islands Pro ...
APR 23, 2021
Microbiology
A Causal Connection Between C-Section Births & Food Allergies
APR 23, 2021
A Causal Connection Between C-Section Births & Food Allergies
The microbes that live in the human gut have a powerful influence on our health, and that microbial community is with us ...
MAY 05, 2021
Immunology
Novel 3D Bio-printed Leukemia Model Shows Potential for Treatment Testing Platform
MAY 05, 2021
Novel 3D Bio-printed Leukemia Model Shows Potential for Treatment Testing Platform
Three-dimensional (3D) printing has become a common technique over the past two decades. Now, the technique has been ado ...
MAY 12, 2021
Immunology
Illuminating the COVID-19 Disease Profile Puzzle
MAY 12, 2021
Illuminating the COVID-19 Disease Profile Puzzle
Teams of science experts from numerous disciplines have been collecting data on SARS-CoV-2 for over a year to understand ...
Loading Comments...